ACE2 and cardiovascular disorder: Previous cardiovascular diseases affect ACE2 levels through RAAS-related pathophysiology and RAAS inhibitors [37], which will not only increase the degree of COVID-19 entering the lung and heart but also have a direct impact on cardiovascular disease, leading to heart injury.